37 related articles for article (PubMed ID: 10658677)
1. Lipopolysaccharide (LPS)-induced macrophage activation and signal transduction in the absence of Src-family kinases Hck, Fgr, and Lyn.
Meng F; Lowell CA
J Exp Med; 1997 May; 185(9):1661-70. PubMed ID: 9151903
[TBL] [Abstract][Full Text] [Related]
2. Fcgamma receptor-mediated phagocytosis in macrophages lacking the Src family tyrosine kinases Hck, Fgr, and Lyn.
Fitzer-Attas CJ; Lowry M; Crowley MT; Finn AJ; Meng F; DeFranco AL; Lowell CA
J Exp Med; 2000 Feb; 191(4):669-82. PubMed ID: 10684859
[TBL] [Abstract][Full Text] [Related]
3. Myeloid Src-family kinases are critical for neutrophil-mediated autoinflammation in gout and motheaten models.
Futosi K; Németh T; Horváth ÁI; Abram CL; Tusnády S; Lowell CA; Helyes Z; Mócsai A
J Exp Med; 2023 Jul; 220(7):. PubMed ID: 37074415
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic cell kinase (HCK) as a therapeutic target in immune and cancer cells.
Poh AR; O'Donoghue RJ; Ernst M
Oncotarget; 2015 Jun; 6(18):15752-71. PubMed ID: 26087188
[TBL] [Abstract][Full Text] [Related]
5. A new role for the SRC family kinase HCK as a driver of SYK activation in MYD88 mutated lymphomas.
Munshi M; Liu X; Kofides A; Tsakmaklis N; Guerrera ML; Hunter ZR; Palomba ML; Argyropoulos KV; Patterson CJ; Canning AG; Meid K; Gustine J; Branagan AR; Flynn CA; Sarosiek S; Castillo JJ; Wang J; Buhrlage SJ; Gray NS; Munshi NC; Anderson KC; Treon SP; Yang G
Blood Adv; 2022 Jun; 6(11):3332-3338. PubMed ID: 35255496
[TBL] [Abstract][Full Text] [Related]
6. Emerging Kinase Therapeutic Targets in Pancreatic Ductal Adenocarcinoma and Pancreatic Cancer Desmoplasia.
Creeden JF; Alganem K; Imami AS; Henkel ND; Brunicardi FC; Liu SH; Shukla R; Tomar T; Naji F; McCullumsmith RE
Int J Mol Sci; 2020 Nov; 21(22):. PubMed ID: 33233470
[TBL] [Abstract][Full Text] [Related]
7. Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomas.
Liu X; Chen JG; Munshi M; Hunter ZR; Xu L; Kofides A; Tsakmaklis N; Demos MG; Guerrera ML; Chan GG; Jimenez C; Patterson CJ; Meid K; Keezer A; Castillo JJ; Treon SP; Yang G
Blood Adv; 2020 Jan; 4(1):141-153. PubMed ID: 31935288
[TBL] [Abstract][Full Text] [Related]
8. Involvement of the HCK and FGR src-family kinases in FCRL4-mediated immune regulation.
Liu Y; Bezverbnaya K; Zhao T; Parsons MJ; Shi M; Treanor B; Ehrhardt GR
J Immunol; 2015 Jun; 194(12):5851-60. PubMed ID: 25972488
[TBL] [Abstract][Full Text] [Related]
9. The class-specific BCR tonic signal modulates lymphomagenesis in a c-myc deregulation transgenic model.
Amin R; Marfak A; Pangault C; Oblet C; Chanut A; Tarte K; Denizot Y; Cogné M
Oncotarget; 2014 Oct; 5(19):8995-9006. PubMed ID: 25229630
[TBL] [Abstract][Full Text] [Related]
10. Novel molecular and cellular therapeutic targets in acute lymphoblastic leukemia and lymphoproliferative disease.
Brown VI; Seif AE; Reid GS; Teachey DT; Grupp SA
Immunol Res; 2008; 42(1-3):84-105. PubMed ID: 18716718
[TBL] [Abstract][Full Text] [Related]
11. Requirement of Src kinases Lyn, Hck and Fgr for BCR-ABL1-induced B-lymphoblastic leukemia but not chronic myeloid leukemia.
Hu Y; Liu Y; Pelletier S; Buchdunger E; Warmuth M; Fabbro D; Hallek M; Van Etten RA; Li S
Nat Genet; 2004 May; 36(5):453-61. PubMed ID: 15098032
[TBL] [Abstract][Full Text] [Related]
12. Lyn tyrosine kinase: accentuating the positive and the negative.
Xu Y; Harder KW; Huntington ND; Hibbs ML; Tarlinton DM
Immunity; 2005 Jan; 22(1):9-18. PubMed ID: 15664155
[TBL] [Abstract][Full Text] [Related]
13. The p60c-src family of protein-tyrosine kinases: structure, regulation, and function.
Brickell PM
Crit Rev Oncog; 1992; 3(4):401-46. PubMed ID: 1384720
[TBL] [Abstract][Full Text] [Related]
14. Characteristic expression of Hck in human B-cell precursors.
Taguchi T; Kiyokawa N; Sato N; Saito M; Fujimoto J
Exp Hematol; 2000 Jan; 28(1):55-64. PubMed ID: 10658677
[TBL] [Abstract][Full Text] [Related]
15. Differential involvement of Src family kinases in Fc gamma receptor-mediated phagocytosis.
Suzuki T; Kono H; Hirose N; Okada M; Yamamoto T; Yamamoto K; Honda Z
J Immunol; 2000 Jul; 165(1):473-82. PubMed ID: 10861086
[TBL] [Abstract][Full Text] [Related]
16. CD19 amplifies B lymphocyte signal transduction by regulating Src-family protein tyrosine kinase activation.
Fujimoto M; Poe JC; Jansen PJ; Sato S; Tedder TF
J Immunol; 1999 Jun; 162(12):7088-94. PubMed ID: 10358152
[TBL] [Abstract][Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
